Voyageur Pharmaceuticals (VYYRF) Financial Statements
Voyageur Pharmaceuticals Financial Overview
Voyageur Pharmaceuticals's market cap is currently $19.44M. The company's EPS TTM is $-0.02; its P/E ratio is -5.53; Voyageur Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Feb 26 | Feb 25 | Feb 24 | Feb 23 | Feb 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 11.69K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -1.22M | $ -1.57K | $ -2.19K | $ -2.91K | $ -2.25K |
| Operating Income | $ -3.53M | $ -1.70M | $ -1.22M | $ -1.75M | $ -2.05M |
| EBITDA | $ -3.53M | $ -1.71M | $ -1.22M | $ -1.74M | $ -2.05M |
| Net Income | $ -3.53M | $ -1.71M | $ -1.40M | $ -1.75M | $ -2.05M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 267.05K | $ 165.57K | $ 2.08K | $ 31.56K | $ 812.97K |
| Total Assets | $ 3.11M | $ 2.60M | $ 2.16M | $ 2.10M | $ 2.57M |
| Total Debt | $ 40.00K | $ 40.00K | $ 40.00K | $ 25.52K | $ 42.08K |
| Net Debt | $ -227.05K | $ -125.57K | $ 37.91K | $ -6.04K | $ -770.89K |
| Total Liabilities | $ 1.85M | $ 2.15M | $ 727.88K | $ 630.83K | $ 660.64K |
| Stockholders' Equity | $ 1.25M | $ 449.96K | $ 1.44M | $ 1.46M | $ 1.91M |
| Cash Flow | |||||
| Free Cash Flow | $ -2.89M | $ -302.29K | $ -991.25K | $ -2.00M | $ -2.09M |
| Operating Cash Flow | $ -2.89M | $ -302.29K | $ -991.25K | $ -1.72M | $ -1.65M |
| Investing Cash Flow | $ -270.02K | $ -165.96K | $ -174.72K | $ -274.15K | $ -432.08K |
| Financing Cash Flow | $ 3.26M | $ 631.73K | $ 1.14M | $ 1.21M | $ 2.90M |
Currency in CAD